This is the authors' abstract. We don't add key points for this paper.
A significant proportion of defective green coffee beans (GCBs) are produced during the pre- and post-harvesting processes, reducing overall bean quality. Although GCBs can be used as a source of bioactive compounds, few relevant analyses of such uses have been reported. This study focuses on the characterization and quantification of acyl-quinic acids in 10 different types of defective Coffea arabica GCBs, along with an investigation of their antioxidant capacity. A total of 37 acyl-quinic acids were identified, with 3- p -coumaroyl-4-feruloylquinic acid, 3-feruloyl-4- p -coumaroylquinic acid, 4- p -coumaroyl-5-feruloylquinic acid, and 4-feruloyl-5-dimethoxycinnamoylquinic acid reported for the first time in Arabica GCBs. Defective GCBs (full black, partial black, insect damage, withered, and floater types) had significantly higher acyl-quinic acid contents compared with non-defective GCBs. Among them, the black, insect damage, and withered types had greater antioxidant capacity compared with non-defective beans. These findings suggest that defective GCBs can be viable sources of bioactive compounds for the nutraceutical or pharmaceutical industries. • Thirty-seven acylquinic acids were identified in defective green coffee beans. • 3 p Co-4FQA, 4 p Co-5FQA, and 4F-5dCiQA were first reported in Arabica coffee beans. • 3F-4 p CoQA was identified for the first time in both Arabica and Robusta species. • Five defective beans had higher acylquinic acid content than non-defective beans. • Defective coffee beans can be used as a sustainable source of bioactive compounds.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: